Skip to main content
. 2024 Feb 19;64(4):36. doi: 10.3892/ijo.2024.5624

Figure 4.

Figure 4

CAR-T cell treatment principles and processes. CAR-T cell therapy uses genetically modified T cells to target and eliminate tumor cells. The treatment process involves collecting T cells, modifying them to express CARs, expanding and cultivating these engineered T cells, and ultimately administering them to patients to exert potent antitumor activity. CAR, chimeric antigen receptor; HER, human epidermal growth factor receptor.